Table 1 Demographic of DTC patients
Characteristics | N (%) | |
|---|---|---|
Age (years) | ||
Mean ± SD | 49.9 ± 14.3 | |
Gender | ||
Female | 133 (83.1) | |
Male | 27 (16.9) | |
Follow-up duration (years) | ||
Median (interquartile range) | 4.0 (2.0–7.0) | |
Histology | ||
Papillary | 135 (84.4) | |
Follicular | 17 (10.6) | |
Mixed | 7 (4.4) | |
Hürthle cell | 1 (0.6) | |
TgAb status during thyroid hormone therapy | ||
Positive TgAb (≥40 IU/mL) | 27 (16.9) | |
Negative TgAb (<40 IU/mL) | 133 (83.1) | |
Clinical status at the follow-up | ||
No evidence of disease (NED) | 49 (30.6) | |
Thyroid remnants | 14 (8.8) | |
Biochemical persistent disease | 28 (17.5) | |
Structural persistent disease | 69 (43.1) |